Back
Direxion Daily S&P Biotech Bear 3X ETF Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
LABD
Direxion Daily S&P Biotech Bear 3X ETF
Last Price:
6.56
Seasonality Move:
-5.39%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Direxion Daily S&P Biotech Bear 3X ETF Price Quote
$6.56
-0.04 (-0.61%)
(Updated: November 21, 2024 at 4:35 PM ET)
Direxion Daily S&P Biotech Bear 3X ETF Key Stats
Sell
36
Direxion Daily S&P Biotech Bear 3X ETF (LABD)
is a Sell
Day range:
$6.57 - $6.95
52-week range:
$4.78 - $19.53
Dividend yield:
4.22%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
23.3M
Avg. volume:
19.6M
1-year change:
-64.13%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Direxion Daily S&P Biotech Bear 3X ETF Make?
Data Unavailable
Is Direxion Daily S&P Biotech Bear 3X ETF Growing As A Company?
Data Unavailable
Direxion Daily S&P Biotech Bear 3X ETF Stock Price Performance
-
Did Direxion Daily S&P Biotech Bear 3X ETF Stock Go Up Last Month?
Direxion Daily S&P Biotech Bear 3X ETF share price went up by 16.61% last month -
Did LABD's Share Price Rise Over The Last Year?
LABD share price fell by -64.13% over the past 1 year
What Is Direxion Daily S&P Biotech Bear 3X ETF 52-Week High & Low?
-
What Is Direxion Daily S&P Biotech Bear 3X ETF’s 52-Week High Share Price?
Direxion Daily S&P Biotech Bear 3X ETF has traded as high as $19.53 over the past 52 weeks -
What Is Direxion Daily S&P Biotech Bear 3X ETF’s 52-Week Low Share Price?
Direxion Daily S&P Biotech Bear 3X ETF has traded as low as $4.78 over the past 52 weeks
Direxion Daily S&P Biotech Bear 3X ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Direxion Daily S&P Biotech Bear 3X ETF?
Data Unavailable
Is Direxion Daily S&P Biotech Bear 3X ETF Cash Flow Positive?
Data Unavailable
Direxion Daily S&P Biotech Bear 3X ETF Return On Invested Capital
Data Unavailable
Direxion Daily S&P Biotech Bear 3X ETF Earnings Date & Stock Price
-
What Is Direxion Daily S&P Biotech Bear 3X ETF's Stock Price Today?
A single share of LABD can be purchased today for 6.60 -
What Is Direxion Daily S&P Biotech Bear 3X ETF’s Stock Symbol?
Direxion Daily S&P Biotech Bear 3X ETF trades on the nysearca under the ticker symbol: LABD -
When Is Direxion Daily S&P Biotech Bear 3X ETF’s Next Earnings Date?
The next quarterly earnings date for Direxion Daily S&P Biotech Bear 3X ETF is scheduled on November 21, 2024 -
When Is LABD's next ex-dividend date?
Direxion Daily S&P Biotech Bear 3X ETF's next ex-dividend date is September 24, 2024 -
How To Buy Direxion Daily S&P Biotech Bear 3X ETF Stock?
You can buy Direxion Daily S&P Biotech Bear 3X ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Direxion Daily S&P Biotech Bear 3X ETF Competitors
-
Who Are Direxion Daily S&P Biotech Bear 3X ETF's Competitors?
Below is a list of companies who compete with Direxion Daily S&P Biotech Bear 3X ETF or are related in some way:
Direxion Daily S&P Biotech Bear 3X ETF Dividend Yield
-
What Is LABD Dividend Yield?
Direxion Daily S&P Biotech Bear 3X ETF’s dividend yield currently is 4.22% -
What Is Direxion Daily S&P Biotech Bear 3X ETF’s Payout Ratio?
Direxion Daily S&P Biotech Bear 3X ETF’s payout ratio is 0% -
When Did Direxion Daily S&P Biotech Bear 3X ETF Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Direxion Daily S&P Biotech Bear 3X ETF’s Dividend Per Share?
Direxion Daily S&P Biotech Bear 3X ETF pays a dividend of $0.00 per share
Direxion Daily S&P Biotech Bear 3X ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable